about
Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so farEllagitannins in Cancer Chemoprevention and TherapyA Critical Appraisal of Solubility Enhancement Techniques of PolyphenolsEllagitannins from Rubus berries for the control of gastric inflammation: in vitro and in vivo studiesPhytonutrient intakes in relation to European fruit and vegetable consumption patterns observed in different food surveysIntake of polyphenol-rich pomegranate pure juice influences urinary glucocorticoids, blood pressure and homeostasis model assessment of insulin resistance in human volunteers.Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome.Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention.The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.Anti-inflammatory effects of polyphenolic-enriched red raspberry extract in an antigen-induced arthritis rat model.Sweet chestnut (Castanea sativa Mill.) bark extract: cardiovascular activity and myocyte protection against oxidative damage.Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice.The effects of proresolution of ellagic acid in an experimental model of allergic airway inflammation.Nuclear receptor-mediated alleviation of alcoholic fatty liver by polyphenols contained in alcoholic beverages.Chemical composition of polyphenols extracted from strawberry pomace and their effect on physiological properties of diets supplemented with different types of dietary fibre in rats.The pharmacological use of ellagic acid-rich pomegranate fruit.Quorum sensing and phytochemicals.Natural dibenzo-α-pyrones and their bioactivities.Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Delivery aspects of antioxidants in diabetes management.Dietary polyphenols against metabolic disorders: How far have we progressed in the understanding of the molecular mechanisms of action of these compounds?Optimization of simultaneous microwave/ultrasonic-assisted extraction of phenolic compounds from walnut flour using response surface methodology.Health benefits of walnut polyphenols: An exploration beyond their lipid profile.Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism.New phytochemicals as potential human anti-aging compounds: Reality, promise, and challenges.Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status.Polyphenol compounds and PKC signaling.Novel pharmacological modulators of autophagy: an updated patent review (2012-2015).Ocular inflammation and endoplasmic reticulum stress are attenuated by supplementation with grape polyphenols in human retinal pigmented epithelium cells and in C57BL/6 mice.Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells.The protective effect of a mix of Lactarius deterrimus and Castanea sativa extracts on streptozotocin-induced oxidative stress and pancreatic β-cell death.Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages.Preventive Effect of Three Pomegranate (Punica granatum L.) Seeds Fractions on Cerulein-Induced Acute Pancreatitis in Mice.Vasorelaxant and Hypotensive Effects of Jaboticaba Fruit (Myrciaria cauliflora) Extract in Rats.Acute effects of pomegranate extract on postprandial lipaemia, vascular function and blood pressure.Edible Myrciaria vexator fruits: bioactive phenolics for potential COPD therapy.Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid.Nutritional composition and antioxidant capacity in edible flowers: characterisation of phenolic compounds by HPLC-DAD-ESI/MSn.Self nanoemulsifying drug delivery system of stabilized ellagic acid-phospholipid complex with improved dissolution and permeabilityPomegranate Intake Protects Against Genomic Instability Induced by Medical X-rays In Vivo in Mice.
P2860
Q21285097-0CF3A111-2963-41E9-9BA7-0C8C9C15F167Q26748955-F35FB1D4-FC9E-466E-BD60-6DDF717D33F4Q26852410-0F3A112A-03DE-40D2-AC45-616B75B62EB1Q27309147-A5037D5F-0358-4E3D-8C56-A65635DDA7C6Q30589838-B335F5F8-435D-4661-A77B-6703299D04F5Q34125784-1C037179-A4A7-4DD7-BDEB-0B86C2753756Q34915903-60EF968F-AFE2-4E0E-AAF1-B4FD9E638956Q34977600-7B8A9EDE-39EF-4FA0-A3C4-C60E4638DFA4Q35598535-DAC784E9-A241-4BD8-86B6-1E89C42F1C54Q35836496-13190463-C5C5-4A45-9E91-DFE3D6789366Q36692053-5A8CF2CE-606F-418E-998F-2F1F616FB9F2Q36692058-D09949B2-359A-4E98-9480-7E87663BD161Q37385758-BD1F13A1-FD99-48DA-A70E-F0533FAEDF1AQ37548530-F0EE4643-824B-43C7-9DE8-401E2A882293Q37585962-F37B5E68-8669-4EF9-A71E-CFFEF0473A6CQ38108784-875CDF84-0945-4E85-8601-9F82849665CEQ38115127-65207626-9DF0-4DB9-B26A-3E08D7EA8B90Q38206630-60C3A180-40BF-4948-9454-13A78C9E2D0EQ38245598-5C1ED4B2-E731-413B-950C-C889D2BFE9FAQ38315902-F8C9E697-3040-49D2-A7E8-8093AA2E725AQ38521024-6DAAE222-C3D7-4D0E-886C-F111AC87455CQ38664414-45D0B948-C239-4BB1-9E2D-6D8139869E3BQ38682113-36E45344-28AB-4C62-B518-1334D26C8C7EQ38810847-2EF14180-E8CF-4AEF-A64C-D63405C6818FQ38821695-010BFEA3-7E84-490C-85B0-1A49617924F6Q38829534-B92A91A6-642A-42D2-BCDC-E6D69327EDD6Q38846159-E9C0BDA1-330B-4A41-9F87-209D3FE33DE3Q38914171-C2B54A9B-6392-46FC-BA66-4BD4E66B7F84Q39008193-3A0C165D-3BBC-4A8C-8F09-0D00321578F2Q39090075-42520B93-9F7A-4D52-BBC6-63CE71950D07Q39424797-54401806-4B1D-42A7-AADE-8383FD43FB72Q39469616-4A44B78D-024E-472E-9486-326CD0BEBE8BQ39529757-4D127B4B-DCC9-4019-9F79-7B8384A02E68Q40031299-83ECE951-5067-4FAE-B0B6-03A7149B75FAQ40070920-BD232DAC-60C2-4160-9629-8C7FE04774EEQ40968386-1B836556-C3D4-4177-9BFB-3B468F11B0E4Q41269505-8329B7FE-FCE6-4DDC-B0F9-A3B548F31F7AQ42273113-04EB2D50-B43E-4A3C-A86A-18D824A71468Q42274166-7498D56A-E43E-41D6-8525-7022E9FB820BQ43110172-86CA5BF1-E94C-4088-9A14-7C32CE3FACB7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ellagitannins, ellagic acid and vascular health.
@en
Ellagitannins, ellagic acid and vascular health.
@nl
type
label
Ellagitannins, ellagic acid and vascular health.
@en
Ellagitannins, ellagic acid and vascular health.
@nl
prefLabel
Ellagitannins, ellagic acid and vascular health.
@en
Ellagitannins, ellagic acid and vascular health.
@nl
P2093
P50
P1476
Ellagitannins, ellagic acid and vascular health
@en
P2093
Francisco A Tomás-Barberán
Mar Larrosa
María T García-Conesa
P304
P356
10.1016/J.MAM.2010.09.005
P577
2010-09-15T00:00:00Z